2018-04-17: Comments: Adding CDXS (pivot buy point $11.95, 6-week cup-and-handle base, curr/next qtr upward earn revisions +31%/+3%, curr year growth est +51%, biotech momentum play, Industry Group Rank #3, Relative Strength Rank 98, stop $11, trade risk -8%), PGTI (pivot buy point $19.15, 8-week flat base, pocket pivot in base, curr year growth est +40%, ROE 26%, exhibiting margin expansion in last quarter, Industry Group Rank #42, Relative Strength Rank 92, stop $18.19, trade risk -5%) - BOTH HALF POSITIONS ONLY.

Adjusting pivot buy point on SUPV to $30.34 (today's high), with a -2% stop at $29.72. 

2018-04-13: Comments: Adding APEI (pivot buy point $44.44, 5-weeks tight base, upward earnings estimate revisions, current year estimated growth +18.35%, recent qtr EPS $0.23, $0.27, $0.51, under institutional accumulation, Industry Group Rank #29, Relative Strength Rank 99, trade risk -6%, stop $41.6 - HALF POSITION ONLY) to the Watch List for Friday, April 13, 2018.

2018-04-10: Comments: Adding SUPV (pivot buy point $31.55, 12-week cup-and-handle base, upward earnings estimate revisions, current year earnings growth +28%, under institutional accumulation, ROE 21%, Industry Group Rank #1, Relative Strength Rank 93, trade risk -5%, stop $29.97 - STARTER HALF POSITION ONLY) to the Watch List for Wednesday, April 11, 2018.

2018-04-02: Comments: We were stopped out of TBK at +2.35% and ASML at -3.77%, and are now 100% in cash.

2018-04-01: Comments: Raising stops on ASML to $193.18. On a programming note, we have redesigned our stock screener to allow you to screen all 6000+ US stocks for different technical, fundamental and trend criteria. Our home and member pages also have a bit of a face lift, so please check them out and provide any feedback you may have. Happy Easter!

2018-03-29: Comments: We were stopped out of our remaining APTI at +18.2% and ARGX at -6.2%.

2018-03-28: Comments: We were stopped out of SAIA at -5.2%. Maintain tight stops in this higher volatility environment.

2018-03-25: Comments: We were stopped out of FLT at -5.24%.

2018-03-22: Comments: We were stopped out of WB at -5%.

2018-03-21: Comments: Watch List candidates FLT and SAIA triggered their buy points, and were purchased for the GSA Portfolio.

2018-03-20: Comments: Adding SAIA (pivot buy point $77.7, 9-week cup-and-handle base, accelerating sales and earnings growth, expanding profit margins, upward quarterly earnings estimate revisions, current fiscal year est +69%, under institutional accumulation, Relative Strength Rank 91, stop $73.80, trade risk -5%) to the Watch List for Wednesday, March 21, 2018. FLT still on a buy above $210.94.

WB triggered it's pivot point today, and was purchased for the GSA Portfolio.

2018-03-19: Comments: Adding WB (pivot buy point $134.91, 4-week constructive base, upward earnings estimate revisions, curr year earn est +60%, accelerating last 4 qtr EPS and sales of $0.21, $0.33, $0.45, $0.58 and $199M, $253M, $320M, $377M respectively, margin expansion, earnings surpise in last 4/4 quarters, ROE 35%, Industry Group Rank #6, Relative Strength Rank 96, stop $128.16, trade risk -5%) to the Watch List for Tuesday, March 20, 2018.

We were stopped out of LGND at +4% and ABBV at -6.3%. 

2018-03-18: Comments: Raising stops on APTI to $27.98, TBK to $39.97, ABBV to $111.50, LGND to $167.70. FLT on Watch List above $210.94.

2018-03-15: Comments: We sold half our position in APTI at a profit of +28%, and now trail the balance at a stop of $27.82 (3-ATR).

2018-03-15: Comments: Adding FLT (pivot buy point $210.94, 8-week cup-and-handle base, quarterly earnings accelerating, under insitutional accumulation, curr year earn est +20%, ROE 21%, Industry Group Rank #4, Relative Strength Rank 87, stop $199.95, trade risk -5%) to the Watch List for Friday, March 16, 2018.

2018-03-13: Comments: We were stopped out of ATRA at -8.7%.

2018-03-11: Comments: Watch List Candidate ATRA triggered it's buy point Friday, and was purchased for the GSA Portfolio. Raising stops on APTI to $26.87 (3-ATR), TBK to $39.30 (3-ATR), LGND to $162 (3-ATR). 

2018-03-08: Comments: Adding ATRA (pivot buy point $44.80, 3-week cup-and-handle pattern on a high tight flag, biotech momentum play only, Industry Group Rank #2, Relative Strength Rank 99, trade risk -8%, stop $41.22 - HALF POSITION ONLY DUE TO EXISTING BIOTECH EXPOSURE) to the Watch List for Friday, March 9, 2018.

2018-03-06: Comments: Watch List candidate ASML triggered it's buy point, and was purchased for the GSA Portfolio.

2018-03-05: Comments: Adding ASML (pivot buy point $201, 6-week cup-and-handle base, curr/next year earn est +31%/+24%, under institutional accumulation, ROE 21%, Relative Strength Rank 91, stop $188.94, trade risk -6%) to the Watch List for Tuesday, March 6, 2018. LGND also triggered it's buy point, and was purchased for the GSA Portfolio.